Basics Vir Biotechnology, Inc. IPO Date: October 11, 2019 Sector: Healthcare Industry: Biotech Market Cap: $871.01M Activated in VL: True Average Daily Range Avg Daily Range: $0.85 | 3.13% Avg Daily Range (30 D): $0.14 | 2.50% Avg Daily Range (90 D): $0.13 | 2.47% Institutional Daily Volume Avg Daily Volume: .98M Avg Daily Volume (30 D): 1.21M Avg Daily Volume (90 D): 1.1M Trade Size Avg Trade Size (Sh.): 80 Avg Trade Size (Sh.) (30 D): 102 Avg Trade Size (Sh.) (90 D): 99 Institutional Trades Total Inst.Trades: 3,008 Avg Inst. Trade: $2.48M Avg Inst. Trade (30 D): $.85M Avg Inst. Trade (90 D): $.91M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.56M Avg Closing Trade (30 D): $.87M Avg Closing Trade (90 D): $.88M Avg Closing Volume: 179.87K     News Aug 7, 2025 @ 4:32 AM Vir (VIR) Q2 Revenue Drops 61% Source: Jesterai Jun 6, 2024 @ 5:29 PM Biotech Stock Roundup: GSK's Litigation Update, BI... Source: Zacks Equity Research Jun 6, 2024 @ 5:26 PM Vir Biotechnology (VIR) Up on Positive Data From H... Source: Zacks Equity Research May 24, 2024 @ 5:01 PM Evaluating Vir Biotechnology: Insights From 5 Fina... Source: Benzinga Insights May 7, 2024 @ 1:00 PM Deep Dive Into Vir Biotechnology Stock: Analyst Pe... Source: Benzinga Insights Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.8 $-.88 Diluted EPS $-.8 $-.88 Revenue $ $ 1.21M $ 3.03M Gross Profit $ $ 1.2M $ 3.03M Net Income / Loss $ $ -110.96M $ -120.97M Operating Income / Loss $ $ -118.42M $ -139.55M Cost of Revenue $ $ .01M $ M Net Cash Flow $ $ -61.72M $ 49.3M PE Ratio